This inventor holds 1 USPTO granted patent. Top assignee: Kpc Pharmaceuticals, Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Xi Huang - Innovator in Respiratory Health
Introduction
Xi Huang is a notable inventor based in Yunnan, China. He has made significant contributions to the biopharmaceutical field, particularly in the development of treatments for respiratory diseases. His innovative work focuses on the use of Trezastilbenoside, a compound with promising therapeutic effects.
Latest Patents
Xi Huang holds a patent for the "Use of Trezastilbenoside in manufacture of product for treating and/or preventing disease of respiratory system." This patent highlights the efficacy of Trezastilbenoside in alleviating symptoms such as cough, phlegm, and asthma. The results indicate that this compound has significant potential for clinical application in treating respiratory system diseases.
Career Highlights
Xi Huang is currently associated with Kpc Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on respiratory health, showcasing his dedication to improving patient outcomes.
Collaborations
Xi Huang collaborates with talented individuals in his field, including Yidan Liu and Xujuan Yang. Their combined expertise contributes to the innovative projects at Kpc Pharmaceuticals, Inc.
Conclusion
Xi Huang's contributions to the biopharmaceutical industry, particularly in respiratory health, demonstrate his commitment to innovation and patient care. His work with Trezastilbenoside holds promise for future advancements in treating respiratory diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile